Francis Creed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francis Creed has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Barbara Tomenson
6 shared publications- Nusrat Husain
The University of Manchester, UK
5 shared publications - Barbara Tomenson
Biostatistics Unit, Institute of Population Health, The University of Manchester, Jean McFarlane Building, Oxford Road, Manchester, UK
4 shared publications - Gary John Macfarlane
Aberdeen Centre for Arthritis and Musculoskeletal Health (Epidemiology Group), University of Aberdeen, Aberdeen, UK
4 shared publications - Barbara Tomenson
Biostatistics Unit, Institute of Population Health, The University of Manchester, Manchester, UK
3 shared publications David G. Thompson
3 shared publications
Latest Publications
- Open Access
- 1 June 2026
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 76  (5) , 326-331
Patients seeking occupational health advice before and after COVID-19
Background: The COVID-19 pandemic led to an increased prevalence of psychological disorder in population-based studies, but the effect on the ability to work has been less well studied, except in health workers. Aims: This study aimed to assess whether there has been an increase in the number of people seeking assistance for psychological problems from the Sheffield Occupational Health Advisory service in the UK since the COVID-19 pandemic. Methods: The study used routinely collected data at Sheffield Occupational Health Advisory Service (SOHAS) to compare the proportion of all new referrals presenting with psychological problems for 3 years prior to (2017â2019) and following the pandemic (2022â2024). Statistical differences were assessed using the chi-square test. Results: Psychological problems were the most common health problem presenting among those seeking advice at SOHAS both before (57.9%) and after the pandemic (61.5%); this was a small, but significant, difference (P < 0.01). In the post-COVID period, phone consultations largely replaced face-to-face appointments, and the patients were slightly younger, less likely to be referred by a GP and less likely to be off work through illness. The advice given post-COVID was more likely to include employment law and disability discrimination. Conclusions: The observed increase in people seeking advice with psychological problems was minor and bore no resemblance to the reported increase in mental health problems in the UK population since the COVID-19 pandemic. There was no evidence that GPs are detecting and referring more patients with psychological problems affecting work performance.
- 1 June 2026
- Published by Oxford University Press (OUP) in Occupational Medicine
- Vol. 76  (5) , 326-331
Open AccessPatients seeking occupational health advice before and after COVID-19
Background: The COVID-19 pandemic led to an increased prevalence of psychological disorder in population-based studies, but the effect on the ability to work has been less well studied, except in health workers. Aims: This study aimed to assess whether there has been an increase in the number of people seeking assistance for psychological problems from the Sheffield Occupational Health Advisory service in the UK since the COVID-19 pandemic. Methods: The study used routinely collected data at Sheffield Occupational Health Advisory Service (SOHAS) to compare the proportion of all new referrals presenting with psychological problems for 3 years prior to (2017â2019) and following the pandemic (2022â2024). Statistical differences were assessed using the chi-square test. Results: Psychological problems were the most common health problem presenting among those seeking advice at SOHAS both before (57.9%) and after the pandemic (61.5%); this was a small, but significant, difference (P < 0.01). In the post-COVID period, phone consultations largely replaced face-to-face appointments, and the patients were slightly younger, less likely to be referred by a GP and less likely to be off work through illness. The advice given post-COVID was more likely to include employment law and disability discrimination. Conclusions: The observed increase in people seeking advice with psychological problems was minor and bore no resemblance to the reported increase in mental health problems in the UK population since the COVID-19 pandemic. There was no evidence that GPs are detecting and referring more patients with psychological problems affecting work performance.
- Open Access
- 24 March 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14
Psychiatric disorders and the onset of self-reported fibromyalgia and chronic fatigue syndrome: The lifelines cohort study
Introduction: This study aimed to assess whether psychiatric disorders predict the onset of fibromyalgia and chronic fatigue syndrome (CFS) which develop in the presence of pre-existing muscle pain or fatigue.Methods: The population-based Lifelines cohort study included 148,614 adults with relevant data for the fibromyalgia study and 136,423 for the CFS study. Participants with prior self-reported fibromyalgia (or CFS) at baseline were excluded from the relevant analysis. At follow-up (mean 2.4 years), new onsets of each syndrome were identified by self-report. Logistic regression was used to identify which of the baseline variables predicted new onsets of each syndrome. The total number of psychiatric disorders (depression, anxiety, burnout, panic disorder, social phobia, agoraphobia, obsessiveâcompulsive, and eating disorders) was used as a predictor. Prior to the analyses the samples were divided into those with and without marked muscle pain (for fibromyalgia analysis) or persistent fatigue (for CFS).Results: During follow-up, there were 685/136,423 (0.5%) new onsets of self-reported FM in participants without marked muscle pain and 281/7481 (3.75%) in those with such pain; for CFS it was 292/124,223 (0.2%) for those without and 192/10,025 (1.9%) for those with baseline fatigue. In both univariate and logistic regression analyses of participants with prior persistent fatigue psychiatric disorder was clearly associated with onset of CFS. This was not so for onset of fibromyalgia in participants with prior muscle pain.Discussion: Although psychiatric disorders did not predict self-reported fibromyalgia or CFS in participants free of pain or fatigue at baseline, in this study psychiatric disorder did predict self-reported CFS in the presence of pre-existing fatigue. Progress in understanding the etiology of these disorders may require studying separately onsets with and without pre-existing key symptoms.
- 24 March 2023
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 14
Open AccessPsychiatric disorders and the onset of self-reported fibromyalgia and chronic fatigue syndrome: The lifelines cohort study
Introduction: This study aimed to assess whether psychiatric disorders predict the onset of fibromyalgia and chronic fatigue syndrome (CFS) which develop in the presence of pre-existing muscle pain or fatigue.Methods: The population-based Lifelines cohort study included 148,614 adults with relevant data for the fibromyalgia study and 136,423 for the CFS study. Participants with prior self-reported fibromyalgia (or CFS) at baseline were excluded from the relevant analysis. At follow-up (mean 2.4 years), new onsets of each syndrome were identified by self-report. Logistic regression was used to identify which of the baseline variables predicted new onsets of each syndrome. The total number of psychiatric disorders (depression, anxiety, burnout, panic disorder, social phobia, agoraphobia, obsessiveâcompulsive, and eating disorders) was used as a predictor. Prior to the analyses the samples were divided into those with and without marked muscle pain (for fibromyalgia analysis) or persistent fatigue (for CFS).Results: During follow-up, there were 685/136,423 (0.5%) new onsets of self-reported FM in participants without marked muscle pain and 281/7481 (3.75%) in those with such pain; for CFS it was 292/124,223 (0.2%) for those without and 192/10,025 (1.9%) for those with baseline fatigue. In both univariate and logistic regression analyses of participants with prior persistent fatigue psychiatric disorder was clearly associated with onset of CFS. This was not so for onset of fibromyalgia in participants with prior muscle pain.Discussion: Although psychiatric disorders did not predict self-reported fibromyalgia or CFS in participants free of pain or fatigue at baseline, in this study psychiatric disorder did predict self-reported CFS in the presence of pre-existing fatigue. Progress in understanding the etiology of these disorders may require studying separately onsets with and without pre-existing key symptoms.
- Open Access
- 30 July 2022
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 28  (3) , 442-453
Risk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study
Francis Creed. J Neurogastroenterol Motil 2022;28:442-53. https://doi.org/10.5056/jnm21041
- 30 July 2022
- Published by The Korean Society of Neurogastroenterology and Motility in Journal of Neurogastroenterology and Motility
- Vol. 28  (3) , 442-453
Open AccessRisk Factors for Self-reported Irritable Bowel Syndrome With Prior Psychiatric Disorder: The Lifelines Cohort Study
Francis Creed. J Neurogastroenterol Motil 2022;28:442-53. https://doi.org/10.5056/jnm21041
- 6 July 2022
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 84  (9) , 1056-1066
The Predictors of Somatic Symptoms in a Population Sample: The Lifelines Cohort Study
Objective: Multiple bodily symptoms predict poor health status, high healthcare use, and onset of functional somatic syndromes. This study aimed to identify the predictors of somatic symptoms with special reference to mental disorders. Methods: The prospective, population-based Lifelines cohort study included 80,888 adults who were followed up for a mean of 2.4 years. At baseline sociodemographic status, self-reported medical disorders, functional somatic syndromes, stress, neuroticism, mental disorders (assessed with Mini-International Neuropsychiatric Interview), health perception, and analgesic use were assessed. These variables were tested as predictors of number of somatic symptoms at follow-up using linear regression analysis, which adjusted for baseline somatic symptoms (n = 65,904). Logistic regression was used to identify the predictors of a persistently high number of somatic symptoms. Results: The strongest predictors of somatic symptoms at follow-up were life events and difficulties score, and number of general medical illnesses/functional somatic syndromes. Neuroticism and mental disorders were also independent predictors in all analyses. Generalized anxiety, major depressive, and panic disorders were all independent predictors when entered individually into the regression analysis. A persistently high number of somatic symptoms were predicted most strongly by functional somatic syndromes, negative health perception, and paracetamol use. Conclusions: Number of somatic symptoms should be regarded as a multifactorial measure with many predictors. Mental disorders form one predictor, but there are other stronger ones, including stress and general medical disorders. The bidirectional relationship between functional somatic syndromes and multiple somatic symptoms is compatible with the notion that perception of bodily symptoms is a key component of both.
- 6 July 2022
- Published by Wolters Kluwer Health in Psychosomatic Medicine
- Vol. 84  (9) , 1056-1066
The Predictors of Somatic Symptoms in a Population Sample: The Lifelines Cohort Study
Objective: Multiple bodily symptoms predict poor health status, high healthcare use, and onset of functional somatic syndromes. This study aimed to identify the predictors of somatic symptoms with special reference to mental disorders. Methods: The prospective, population-based Lifelines cohort study included 80,888 adults who were followed up for a mean of 2.4 years. At baseline sociodemographic status, self-reported medical disorders, functional somatic syndromes, stress, neuroticism, mental disorders (assessed with Mini-International Neuropsychiatric Interview), health perception, and analgesic use were assessed. These variables were tested as predictors of number of somatic symptoms at follow-up using linear regression analysis, which adjusted for baseline somatic symptoms (n = 65,904). Logistic regression was used to identify the predictors of a persistently high number of somatic symptoms. Results: The strongest predictors of somatic symptoms at follow-up were life events and difficulties score, and number of general medical illnesses/functional somatic syndromes. Neuroticism and mental disorders were also independent predictors in all analyses. Generalized anxiety, major depressive, and panic disorders were all independent predictors when entered individually into the regression analysis. A persistently high number of somatic symptoms were predicted most strongly by functional somatic syndromes, negative health perception, and paracetamol use. Conclusions: Number of somatic symptoms should be regarded as a multifactorial measure with many predictors. Mental disorders form one predictor, but there are other stronger ones, including stress and general medical disorders. The bidirectional relationship between functional somatic syndromes and multiple somatic symptoms is compatible with the notion that perception of bodily symptoms is a key component of both.
- Open Access
- 30 January 2022
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 155, 110745
The risk factors for self-reported fibromyalgia with and without multiple somatic symptoms: The Lifelines cohort study
- 30 January 2022
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 155, 110745
Open AccessThe risk factors for self-reported fibromyalgia with and without multiple somatic symptoms: The Lifelines cohort study
- Open Access
- 17 June 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52  (1) , 112-120
Predictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study
Background: It has been claimed that functional somatic syndromes share a common etiology. This prospective population-based study assessed whether the same variables predict new onsets of irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS) and fibromyalgia (FM).Methods: The study included 152 180 adults in the Dutch Lifelines study who reported the presence/absence of relevant syndromes at baseline and follow-up. They were screened at baseline for physical and psychological disorders, socio-demographic, psycho-social and behavioral variables. At follow-up (mean 2.4 years) new onsets of each syndrome were identified by self-report. We performed separate analyses for the three syndromes including participants free of the relevant syndrome or its key symptom at baseline. LASSO logistic regressions were applied to identify which of the 102 baseline variables predicted new onsets of each syndrome.Results: There were 1595 (1.2%), 296 (0.2%) and 692 (0.5%) new onsets of IBS, CFS, and FM, respectively. LASSO logistic regression selected 26, 7 and 19 predictors for IBS, CFS and FM, respectively. Four predictors were shared by all three syndromes, four predicted IBS and FM and two predicted IBS and CFS but 28 predictors were specific to a single syndrome. CFS was more distinct from IBS and FM, which predicted each other.Conclusions: Syndrome-specific predictors were more common than shared ones and these predictors might form a better starting point to unravel the heterogeneous etiologies of these syndromes than the current approach based on symptom patterns. The close relationship between IBS and FM is striking and requires further research.
- 17 June 2020
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 52  (1) , 112-120
Open AccessPredictors of new onsets of irritable bowel syndrome, chronic fatigue syndrome and fibromyalgia: the lifelines study
Background: It has been claimed that functional somatic syndromes share a common etiology. This prospective population-based study assessed whether the same variables predict new onsets of irritable bowel syndrome (IBS), chronic fatigue syndrome (CFS) and fibromyalgia (FM).Methods: The study included 152 180 adults in the Dutch Lifelines study who reported the presence/absence of relevant syndromes at baseline and follow-up. They were screened at baseline for physical and psychological disorders, socio-demographic, psycho-social and behavioral variables. At follow-up (mean 2.4 years) new onsets of each syndrome were identified by self-report. We performed separate analyses for the three syndromes including participants free of the relevant syndrome or its key symptom at baseline. LASSO logistic regressions were applied to identify which of the 102 baseline variables predicted new onsets of each syndrome.Results: There were 1595 (1.2%), 296 (0.2%) and 692 (0.5%) new onsets of IBS, CFS, and FM, respectively. LASSO logistic regression selected 26, 7 and 19 predictors for IBS, CFS and FM, respectively. Four predictors were shared by all three syndromes, four predicted IBS and FM and two predicted IBS and CFS but 28 predictors were specific to a single syndrome. CFS was more distinct from IBS and FM, which predicted each other.Conclusions: Syndrome-specific predictors were more common than shared ones and these predictors might form a better starting point to unravel the heterogeneous etiologies of these syndromes than the current approach based on symptom patterns. The close relationship between IBS and FM is striking and requires further research.
- 6 February 2020
- Published by Wolters Kluwer Health in Pain
- Vol. 161  (6) , 1169-1176
A review of the incidence and risk factors for fibromyalgia and chronic widespread pain in population-based studies
This review identified prospective cohort studies in the general population, which showed incidence (23 papers) and risk factors (37 papers) for fibromyalgia and chronic widespread pain. Median incidence of physician diagnosed fibromyalgia in the general population was 4.3 per 1000 person-years (range = 0.33-18.8) but 14.0 (1.2-32.7) if medical illness was present. Median incidence of chronic widespread pain was 12.5 per 1000 person-years (7.2-81.6) but 67 per 1000 person years (14.8-124) for those with pre-existing pain. Risk factors included various childhood difficulties, female sex (except with pre-existing medical disorders), older/middle age, smoking, high body mass index, alcohol abstinence, and pre-existing medical disorders in adulthood. The strongest associations were with sleep disorders, headaches and other pains, depression, and illness behaviour. These data suggest strongly that there are many aetiological routes into fibromyalgia, and future research could be enhanced by studying the underlying mechanisms relating to these risk factors.
- 6 February 2020
- Published by Wolters Kluwer Health in Pain
- Vol. 161  (6) , 1169-1176
A review of the incidence and risk factors for fibromyalgia and chronic widespread pain in population-based studies
This review identified prospective cohort studies in the general population, which showed incidence (23 papers) and risk factors (37 papers) for fibromyalgia and chronic widespread pain. Median incidence of physician diagnosed fibromyalgia in the general population was 4.3 per 1000 person-years (range = 0.33-18.8) but 14.0 (1.2-32.7) if medical illness was present. Median incidence of chronic widespread pain was 12.5 per 1000 person-years (7.2-81.6) but 67 per 1000 person years (14.8-124) for those with pre-existing pain. Risk factors included various childhood difficulties, female sex (except with pre-existing medical disorders), older/middle age, smoking, high body mass index, alcohol abstinence, and pre-existing medical disorders in adulthood. The strongest associations were with sleep disorders, headaches and other pains, depression, and illness behaviour. These data suggest strongly that there are many aetiological routes into fibromyalgia, and future research could be enhanced by studying the underlying mechanisms relating to these risk factors.
- 17 July 2019
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 50  (5) , 507-516
Review article: the incidence and risk factors for irritable bowel syndrome in populationâbased studies
Summary: Background: In the absence of prior gastrointestinal infection, the risk factors for irritable bowel syndrome (IBS) are not well established.Aim: To identify the incidence and risk factors for IBS in general population samplesMethods: Narrative review of populationâbased studies. Electronic databases were searched using the keywords âincidence,â âonset,â âepidemiology,â âpopulation,â ârisk factorsâ with âirritable bowel syndromeâ with subsequent hand searching. Inclusion criteria were: populationâbased, adults, prospective design (including retrospective case cohorts), clinical or research diagnosis of IBS and exclusion of individuals who had IBS prior to recruitment.Results: Of 1963 papers, 38 were included; all provided data on risk factors, 27 reported incidence. The median incidence of physicianâdiagnosed IBS in 19 general population cohorts was 38.5 per 10 000 personâyears (interquartile range = 20â45.3). In 14 cohorts with specific medical disorders, median incidence was 92 per 10 000 personâyears (IQR: 73.9â119). Apart from gastroenteritis, the most common risk factors were other medical disorders, female sex, age (both young and old), anxiety and depression, life events/stress, frequent healthcare use, pain and sleep disorders. The results were conflicting for alcohol consumption, smoking and BMI. Incidence rates were similar in different countries but risk factors differed.Conclusions: Incidence rates were generally lower than previous estimates reflecting physicianâdiagnosed IBS. The results highlight the importance of other medical and psychosocial problems in the onset of IBS in addition to prior gastrointestinal infections. Aetiological research could be enhanced by studying the underlying mechanisms relating to all of these risk factors.
- 17 July 2019
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 50  (5) , 507-516
Review article: the incidence and risk factors for irritable bowel syndrome in populationâbased studies
Summary: Background: In the absence of prior gastrointestinal infection, the risk factors for irritable bowel syndrome (IBS) are not well established.Aim: To identify the incidence and risk factors for IBS in general population samplesMethods: Narrative review of populationâbased studies. Electronic databases were searched using the keywords âincidence,â âonset,â âepidemiology,â âpopulation,â ârisk factorsâ with âirritable bowel syndromeâ with subsequent hand searching. Inclusion criteria were: populationâbased, adults, prospective design (including retrospective case cohorts), clinical or research diagnosis of IBS and exclusion of individuals who had IBS prior to recruitment.Results: Of 1963 papers, 38 were included; all provided data on risk factors, 27 reported incidence. The median incidence of physicianâdiagnosed IBS in 19 general population cohorts was 38.5 per 10 000 personâyears (interquartile range = 20â45.3). In 14 cohorts with specific medical disorders, median incidence was 92 per 10 000 personâyears (IQR: 73.9â119). Apart from gastroenteritis, the most common risk factors were other medical disorders, female sex, age (both young and old), anxiety and depression, life events/stress, frequent healthcare use, pain and sleep disorders. The results were conflicting for alcohol consumption, smoking and BMI. Incidence rates were similar in different countries but risk factors differed.Conclusions: Incidence rates were generally lower than previous estimates reflecting physicianâdiagnosed IBS. The results highlight the importance of other medical and psychosocial problems in the onset of IBS in addition to prior gastrointestinal infections. Aetiological research could be enhanced by studying the underlying mechanisms relating to all of these risk factors.
- Open Access
- 1 September 2018
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 112, 1-8
The associated features of multiple somatic symptom complexes
- 1 September 2018
- Published by Elsevier in Journal of Psychosomatic Research
- Vol. 112, 1-8
Open AccessThe associated features of multiple somatic symptom complexes
- 19 July 2013
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 42  (6) , 693-705
Antidepressant and Group Psychosocial Treatment for Depression: A Rater Blind Exploratory RCT from a Low Income Country
Background:Research in the West shows that group psychological intervention together with an antidepressant treatment leads to more effective treatment of a depressive disorder. There are no treatment trials from low income countries comparing the efficacy of antidepressant treatment with a group psychological intervention.Aim:To conduct a feasibility trial to compare the efficacy of an antidepressant to a group psychosocial intervention, for low income women attending primary health care in Karachi, Pakistan.Method:This was a preliminary RCT in an urban primary health care clinic in Karachi, Pakistan. Consecutive eligible women scoring >12 on the CIS-R and >18 on Hamilton Depression Rating Scale (HDRS) (n= 66) were randomly assigned to antidepressants or a psychosocial treatment in group settings. The primary outcome measure was HDRS score; secondary outcome measures were disability and quality of life.Results:More than half of the patients in both groups improved (50% reduction in HDRS scores); at end of therapy at 3 months 19 (59.4%) vs 18 (56.2%), and at 6-month follow-up 21(67.7%) vs 20(62.5%) for antidepressants and psychosocial intervention respectively. Although HDRS, BDQ and EQ5-D scores all improved considerably in both groups from start to end of treatment, and these improvements were largely maintained after a further 3 months, the differences between the two treatments were not statistically significant.Conclusion:Psychosocial intervention was as effective as antidepressants in reducing depression and in improving quality of life and disability at the end of therapy. However, these findings need further exploration through a larger trial.
- 19 July 2013
- Published by Cambridge University Press (CUP) in Behavioural and Cognitive Psychotherapy
- Vol. 42  (6) , 693-705
Antidepressant and Group Psychosocial Treatment for Depression: A Rater Blind Exploratory RCT from a Low Income Country
Background:Research in the West shows that group psychological intervention together with an antidepressant treatment leads to more effective treatment of a depressive disorder. There are no treatment trials from low income countries comparing the efficacy of antidepressant treatment with a group psychological intervention.Aim:To conduct a feasibility trial to compare the efficacy of an antidepressant to a group psychosocial intervention, for low income women attending primary health care in Karachi, Pakistan.Method:This was a preliminary RCT in an urban primary health care clinic in Karachi, Pakistan. Consecutive eligible women scoring >12 on the CIS-R and >18 on Hamilton Depression Rating Scale (HDRS) (n= 66) were randomly assigned to antidepressants or a psychosocial treatment in group settings. The primary outcome measure was HDRS score; secondary outcome measures were disability and quality of life.Results:More than half of the patients in both groups improved (50% reduction in HDRS scores); at end of therapy at 3 months 19 (59.4%) vs 18 (56.2%), and at 6-month follow-up 21(67.7%) vs 20(62.5%) for antidepressants and psychosocial intervention respectively. Although HDRS, BDQ and EQ5-D scores all improved considerably in both groups from start to end of treatment, and these improvements were largely maintained after a further 3 months, the differences between the two treatments were not statistically significant.Conclusion:Psychosocial intervention was as effective as antidepressants in reducing depression and in improving quality of life and disability at the end of therapy. However, these findings need further exploration through a larger trial.